Cyclocoagulation of the Ciliary Bodies by High-Intensity Focused Ultrasound: A 12-Month Multicenter Study [Clinical Trials]

Conclusions.
The new miniaturized HIFU EyeOP1 delivery device seems to be effective in decreasing IOP in patients with refractory glaucoma. The technology offers a good safety profile. (ClinicalTrials.gov number, NCT01338467.)

Source: Investigative Ophthalmology - February 13, 2015 Category: Opthalmology Authors: Denis, P., Aptel, F., Rouland, J.-F., Nordmann, J.-P., Lachkar, Y., Renard, J.-P., Sellem, E., Baudouin, C., Bron, A. Tags: Clinical Trials Source Type: research